Literature DB >> 9389417

Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin.

R B Fraser1, G Rowden, P Colp, J R Wright.   

Abstract

Multiple injections of low-dose streptozotocin induce lymphocytic insulitis and autoimmune diabetes in male CD-1 mice. Prior to the onset of insulitis, macrophages infiltrate the islets (single cell insulitis) and presumably help initiate the lymphocytic response directed at streptozotocin-induced neoantigens on islet beta cells. Essential fatty acid deficiency ameliorates the lymphocytic insulitis and prevents diabetes in this model. We hypothesize that essential fatty acid deficiency, which perturbs eicosanoid pathways and blocks the production of inflammatory mediators such as leukotriene B4, might prevent or diminish the single cell insulitis and, thus, abrogate the lymphocytic response. The purpose of the study was to determine whether essential fatty acid deficiency causes any differences in the immunophenotype or the time course of single cell insulitis or insulitis after low-dose streptozotocin. Three to five essential fatty acid deficient and 3-5 control mice were treated with low-dose streptozotocin and killed on days 0, 3, 5, 8, 10, 12 and 15. Frozen sections of the pancreata were stained using an immunoperoxidase method with antibodies against mouse macrophages, CD4T-lymphocytes and CD8 T-lymphocytes. Sections were assessed for the presence and severity of single cell insulitis and insulitis. Based on cell counts in the most severely involved islet from each pancreas, there was no difference in the single cell insulitis in control and essential fatty acid deficient mice. Islets from control pancreata had a higher mean grade of lymphocytic insulitis. These findings suggest that autoimmune diabetes following low-dose streptozotocin in control mice is the result of both lymphocytic and histiocytic infiltrates with subsequent beta-cell destruction. Our results do not support the hypothesis that the protective effect of essential fatty acid deficiency is due to diminished influx of macrophages into the islets. It is, however, possible that essential fatty acid deficiency deleteriously affects macrophage function and, thus, blunts the lymphocytic response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389417     DOI: 10.1007/s001250050819

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

1.  Essential fatty acid deficiency inhibits the in vivo generation of leukotriene B4 and suppresses levels of resident and elicited leukocytes in acute inflammation.

Authors:  J B Lefkowith
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

2.  The failure of donor essential fatty acid deficiency to prevent renal allograft rejection in rats.

Authors:  J G Lawen; W Yu; H W Cook; J R Wright
Journal:  Transplantation       Date:  1993-11       Impact factor: 4.939

3.  Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice.

Authors:  J R Wright; J B Lefkowith; G Schreiner; P E Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  The antiinflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism.

Authors:  G F Schreiner; B Rovin; J B Lefkowith
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

5.  Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin.

Authors:  K C Herold; A G Montag; F W Fitch
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

6.  Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in naive and cyclosporin-treated low-responder murine strains.

Authors:  J R Wright; R B Fraser; S Kapoor; H W Cook
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

7.  Islet implantation normalises hyperglycaemia caused by streptozotocin-induced insulitis. Experiments in mice.

Authors:  A Andersson
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

8.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

9.  Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.

Authors:  L G Weide; P E Lacy
Journal:  Diabetes       Date:  1991-09       Impact factor: 9.461

10.  The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility.

Authors:  J R Wright; B Haliburton; H Russell; M Henry; R Fraser; H W Cook
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

View more
  1 in total

1.  Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes.

Authors:  Wageh M Awara; Alaa E el-Sisi; Mohamed el-Refaei; Mona M el-Naa; Karima el-Desoky
Journal:  Rev Diabet Stud       Date:  2005-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.